RY 172.7 -0.1792% SHOP 152.38 -3.7762% TD 74.49 -0.4144% ENB 58.66 0.2906% BN 80.21 0.2124% TRI 235.76 -0.7034% CNQ 42.27 -1.3305% CP 102.81 -2.4851% CNR 145.02 -0.9426% BMO 139.15 0.5855% BNS 77.045 -0.149% CSU 4497.2998 0.6756% CM 92.23 -0.335% MFC 43.28 0.8858% ATD 79.0 -1.1882% NGT 53.35 -1.8038% TRP 65.26 0.215% SU 49.61 -1.411% WCN 251.65 -0.2181% L 191.14 0.1205%
Last update at 2024-12-19T18:55:00Z
Zacks Industry Outlook Highlights Elevance Health, Doximity and HealthEquity
Fri 18 Oct 24, 01:09 PM3 Medical Services Stocks to Buy to Navigate Industry Challenges
Thu 17 Oct 24, 03:35 PMHealthEquity Gains 28.3% YTD: What's Driving the Stock?
Wed 16 Oct 24, 05:14 PMHere's Why HealthEquity (HQY) is a Strong Momentum Stock
Wed 16 Oct 24, 01:50 PMHere is Why Growth Investors Should Buy HealthEquity (HQY) Now
Fri 11 Oct 24, 04:45 PMAlignment HealthCare Partners With Intermountain Health in Nevada
Thu 10 Oct 24, 02:10 PMWhy Is HealthEquity (HQY) Down 4.3% Since Last Earnings Report?
Thu 03 Oct 24, 03:30 PMIs HealthEquity Stock a Buy Now Amid Strength in HSAs?
Tue 01 Oct 24, 05:19 PMDoes HealthEquity (NASDAQ:HQY) Deserve A Spot On Your Watchlist?
Wed 25 Sep 24, 05:31 PM| Breakdown | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
| Income before tax | -38.09600M | -66.74100M | 4.14M | 43.16M | 75.82M |
| Minority interest | - | - | - | - | - |
| Net income | -26.14300M | -44.28900M | 8.83M | 39.66M | 73.90M |
| Selling general administrative | 95.63M | 84.38M | 84.49M | 60.56M | 33.04M |
| Selling and marketing expenses | 68.85M | 58.60M | 49.96M | 43.95M | 29.50M |
| Gross profit | 490.09M | 423.71M | 415.33M | 325.91M | 181.19M |
| Reconciled depreciation | 161.20M | 137.19M | 115.90M | 55.35M | 18.18M |
| Ebit | 38.92M | 34.64M | 83.28M | 77.01M | 77.67M |
| Ebitda | 200.12M | 171.82M | 199.18M | 155.39M | 95.86M |
| Depreciation and amortization | 161.20M | 137.19M | 115.90M | 78.38M | 18.18M |
| Non operating income net other | - | - | 5.01M | -9.07900M | -1.85200M |
| Operating income | 38.92M | 34.64M | 83.28M | 77.01M | 77.67M |
| Other operating expenses | 824.10M | 715.99M | 653.57M | 422.88M | 209.57M |
| Interest expense | 48.42M | 36.57M | 34.88M | 24.77M | 0.00000M |
| Tax provision | -11.95300M | -22.45200M | -4.69400M | 3.49M | 1.92M |
| Interest income | 1.76M | 1.50M | 1.04M | 5.91M | - |
| Net interest income | -46.66100M | -36.57200M | -34.88100M | -18.86700M | - |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | 45.99M | 32.11M | - |
| Other items | - | - | - | - | - |
| Income tax expense | -11.95300M | -22.45200M | -4.69400M | 3.49M | 1.92M |
| Total revenue | 861.75M | 756.56M | 733.57M | 531.99M | 287.24M |
| Total operating expenses | 452.44M | 383.14M | 335.33M | 216.79M | 103.52M |
| Cost of revenue | 371.66M | 332.85M | 318.24M | 206.08M | 106.05M |
| Total other income expense net | -77.02000M | -101.37700M | -79.13800M | -33.85100M | -1.85200M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -26.14300M | -44.28900M | 8.83M | 39.66M | 73.90M |
| Net income applicable to common shares | -26.14300M | -44.28900M | 8.83M | 39.66M | 73.90M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 |
| Total assets | 3236.50M | 3088.90M | 3107.10M | 2710.01M | 2565.18M |
| Intangible assets | 835.95M | 936.36M | 973.14M | 767.00M | 783.28M |
| Earning assets | - | - | - | - | - |
| Other current assets | 48.56M | 31.79M | 38.49M | 58.61M | 33.79M |
| Total liab | 1201.48M | 1193.26M | 1254.53M | 1331.28M | 1534.89M |
| Total stockholder equity | 2035.02M | 1895.64M | 1852.58M | 1378.73M | 1030.30M |
| Deferred long term liab | - | - | 4.40M | 5.00M | 6.40M |
| Other current liab | 95.65M | 89.50M | 104.72M | 126.15M | 96.69M |
| Common stock | 0.00900M | 0.00800M | 0.00800M | 0.00800M | 0.00700M |
| Capital stock | 0.00900M | 0.00800M | 0.00800M | 0.00800M | 0.00700M |
| Retained earnings | 205.63M | 149.92M | 176.06M | 220.35M | 211.51M |
| Other liab | - | 95.37M | 114.03M | 128.54M | 133.12M |
| Good will | 1648.14M | 1648.14M | 1645.84M | 1326.79M | 1334.13M |
| Other assets | 0.00000M | 52.18M | 49.81M | 37.42M | 35.11M |
| Cash | 403.98M | 254.27M | 225.41M | 328.80M | 191.73M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 117.09M | 131.06M | 153.19M | 204.30M | 152.14M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 529.16M | 740.22M | 782.82M | 746.17M | 1109.37M |
| Short term debt | 9.40M | 27.66M | 20.92M | 76.54M | 51.46M |
| Short long term debt | - | 17.50M | 8.75M | 62.50M | 39.06M |
| Short long term debt total | 933.14M | 994.49M | 1008.23M | 1074.98M | 1301.10M |
| Other stockholder equity | 1829.38M | 1745.72M | 1676.51M | 1158.37M | 818.77M |
| Property plant equipment | - | 69.32M | 86.98M | 118.61M | 33.49M |
| Total current assets | 557.44M | 382.89M | 351.34M | 460.18M | 296.00M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | -688.86400M | -766.39800M | -715.06800M | -1085.61500M |
| Short term investments | - | - | - | - | - |
| Net receivables | 104.89M | 96.83M | 87.43M | 72.77M | 70.48M |
| Long term debt | 874.97M | 907.84M | 922.08M | 924.22M | 1181.62M |
| Inventory | - | - | - | - | - |
| Accounts payable | 12.04M | 13.90M | 27.54M | 1.61M | 3.98M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 0.00000M | - | - | - | -15.75700M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | 0.00800M | 0.00700M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | 220.35M | 211.51M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | -768.08000M | 52.18M | 49.81M | 37.42M | 35.09M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 2679.06M | 2706.01M | 2755.76M | 2249.83M | 2269.18M |
| Capital lease obligations | 58.17M | 69.15M | 77.40M | 88.26M | 80.42M |
| Long term debt total | - | - | - | - | 1181.62M |
| Breakdown | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
| Investments | -119.12700M | 2.37M | -96.96400M | -53.84500M | 40.69M |
| Change to liabilities | -26.67300M | -2.17800M | 30.42M | 6.47M | 8.33M |
| Total cashflows from investing activities | -119.12700M | -639.24700M | -96.96400M | -1740.49400M | 25.65M |
| Net borrowings | -8.75000M | -53.12500M | -239.06300M | 1211.68M | 1242.19M |
| Total cash from financing activities | -2.67100M | 394.86M | 52.42M | 1467.74M | 22.93M |
| Change to operating activities | 2.87M | 15.01M | -17.71400M | -1.51600M | 2.14M |
| Net income | -26.14300M | -44.28900M | 8.83M | 39.66M | 73.90M |
| Change in cash | 28.85M | -103.38900M | 137.08M | -169.74900M | 162.00M |
| Begin period cash flow | 225.41M | 328.80M | 191.73M | 361.48M | 199.47M |
| End period cash flow | 254.27M | 225.41M | 328.80M | 191.73M | 361.48M |
| Total cash from operating activities | 150.65M | 141.00M | 181.62M | 105.86M | 113.42M |
| Issuance of capital stock | 0.00000M | 456.64M | 286.78M | 458.50M | - |
| Depreciation | 161.20M | 137.19M | 115.90M | 55.35M | 18.18M |
| Other cashflows from investing activities | - | - | -83.87100M | -1679.36300M | -11.17300M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | - | - | -30.42200M | -4.10100M | -2.28900M |
| Change to account receivables | -9.57000M | -11.20400M | -0.41300M | -6.12700M | -4.30600M |
| Sale purchase of stock | - | - | 295.35M | 469.84M | 22.93M |
| Other cashflows from financing activities | -0.60300M | 941.35M | 4.71M | 1017.06M | 22.93M |
| Change to netincome | 45.70M | 42.02M | 39.48M | 20.36M | 21.70M |
| Capital expenditures | 119.13M | 137.08M | 96.96M | 42.07M | 15.04M |
| Change receivables | - | - | -0.41300M | -5.00900M | -4.30600M |
| Cash flows other operating | - | - | -18.48500M | -11.82500M | -5.32000M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | 137.08M | -169.74900M | 162.00M |
| Change in working capital | -33.37000M | 1.62M | 12.29M | -9.51700M | -1.30000M |
| Stock based compensation | 62.61M | 52.75M | 42.86M | 39.84M | 21.06M |
| Other non cash items | 3.53M | 17.15M | 6.86M | -23.15100M | 1.17M |
| Free cash flow | 31.52M | 3.91M | 84.66M | 63.78M | 98.38M |
Sector: Healthcare Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HQY HealthEquity Inc |
3.08 3.36% | 94.62 | 123.86 | 42.37 | 6.88 | 3.38 | 7.41 | 26.13 |
| GEHC GE HealthCare Technologies Inc. |
0.62 0.80% | 77.71 | 22.91 | 20.12 | 2.01 | 5.52 | 2.39 | 13.30 |
| VEEV Veeva Systems Inc Class A |
-2.02 0.91% | 219.52 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
| MTHRF M3 Inc |
- -% | 9.73 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
| MTHRY M3 Inc |
-0.13 2.97% | 4.25 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
15 West Scenic Pointe Drive, Draper, UT, United States, 84020
| Name | Title | Year Born |
|---|---|---|
| Mr. Jon Kessler | Pres, CEO & Director | 1968 |
| Mr. Tyson Murdock | Exec. VP & CFO | 1971 |
| Mr. Darcy G. Mott | Special Advisor | 1953 |
| Mr. Larry L. Trittschuh | Exec. VP & Chief Security Officer | 1972 |
| Mr. Elimelech Rosner | Exec. VP & CTO | 1957 |
| Mr. Richard Putnam | VP of Investor Relations | NA |
| Mr. Delano Ladd | Exec. VP, Gen. Counsel & Sec. | 1981 |
| Mr. Steve Lindsay | Exec. VP of Sales & Relationship Management | NA |
| Mr. Brad Bennion | Sr. VP of Corp. Devel. | NA |
| Ms. Tia Padia | Sr. VP of Marketing | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA 
AU
UK
US
NZ
Please wait processing your request...